07ghsot
2019-01-23
$梯瓦制药(TEVA)$今天怎么了 有利好吗
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
小土豪1996
2019-01-23
小土豪1996
有 瑞士银行在购买DJ Teva制药公司
07ghsot
:
完了.我在做空
小土豪1996
2019-01-23
小土豪1996
格林尼治时间1015英镑-瑞银(UBS)表示，华尔街高估了Teva的偿债风险，因为其下行模式显示，除了债务需求之外，还有20亿美元的现金。蒂瓦过去的五年受到了糟糕交易和激烈竞争的影响，这使得这家以色列制药公司债台高筑，股价下跌了60%，但瑞银表示，未来前景更加乐观：奥斯特多、阿乔维和生物仿制药将主要抵消基础压力。瑞士银行的纸币显示，更大的开支节省也将帮助其交易走高。瑞银发起购买保险。特拉维夫上市公
什么也没有了～
APP内打开
发表看法
3
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":385718,"tweetId":"385718","gmtCreate":1548244992456,"gmtModify":1704787660671,"author":{"id":3483164320744267,"idStr":"3483164320744267","authorId":3483164320744267,"authorIdStr":"3483164320744267","name":"07ghsot","avatar":"https://static.laohu8.com/c74097cb12e598c87ad88e9eb3ff0335","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":10,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$梯瓦制药(TEVA)$今天怎么了 有利好吗</p></body></html>","htmlText":"<html><head></head><body><p>$梯瓦制药(TEVA)$今天怎么了 有利好吗</p></body></html>","text":"$梯瓦制药(TEVA)$今天怎么了 有利好吗","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/385718","repostId":0,"isVote":1,"tweetType":1,"viewCount":4042,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["TEVA"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":34,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":1292549,"commentId":"1292549","gmtCreate":1548251830406,"gmtModify":1548251830406,"authorId":3488280287419675,"author":{"id":3488280287419675,"idStr":"3488280287419675","authorId":3488280287419675,"name":"小土豪1996","avatar":"https://static.tigerbbs.com/d390a1b13d5be340442abaafc8be2b04","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":385718,"objectIdStr":"385718","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"有 瑞士银行在购买DJ Teva制药公司 \n<br> \n<br> \n<br>","text":"有 瑞士银行在购买DJ Teva制药公司 \n<br> \n<br> \n<br>","html":"有 瑞士银行在购买DJ Teva制药公司 \n<br> \n<br> \n<br>","likeSize":0,"commentSize":1,"subComments":[{"id":1292553,"commentId":"1292553","gmtCreate":1548251858139,"gmtModify":1548251858139,"authorId":3483164320744267,"author":{"id":3483164320744267,"idStr":"3483164320744267","authorId":3483164320744267,"name":"07ghsot","avatar":"https://static.laohu8.com/c74097cb12e598c87ad88e9eb3ff0335","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":385718,"objectIdStr":"385718","type":1,"supId":1292549,"supIdStr":"1292549","prevId":0,"prevIdStr":"0","content":"完了.我在做空","text":"完了.我在做空","html":"完了.我在做空"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":1292564,"commentId":"1292564","gmtCreate":1548252023097,"gmtModify":1548252023097,"authorId":3488280287419675,"author":{"id":3488280287419675,"idStr":"3488280287419675","authorId":3488280287419675,"name":"小土豪1996","avatar":"https://static.tigerbbs.com/d390a1b13d5be340442abaafc8be2b04","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":385718,"objectIdStr":"385718","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"格林尼治时间1015英镑-瑞银(UBS)表示，华尔街高估了Teva的偿债风险，因为其下行模式显示，除了债务需求之外，还有20亿美元的现金。蒂瓦过去的五年受到了糟糕交易和激烈竞争的影响，这使得这家以色列制药公司债台高筑，股价下跌了60%，但瑞银表示，未来前景更加乐观：奥斯特多、阿乔维和生物仿制药将主要抵消基础压力。瑞士银行的纸币显示，更大的开支节省也将帮助其交易走高。瑞银发起购买保险。特拉维夫上市公","text":"格林尼治时间1015英镑-瑞银(UBS)表示，华尔街高估了Teva的偿债风险，因为其下行模式显示，除了债务需求之外，还有20亿美元的现金。蒂瓦过去的五年受到了糟糕交易和激烈竞争的影响，这使得这家以色列制药公司债台高筑，股价下跌了60%，但瑞银表示，未来前景更加乐观：奥斯特多、阿乔维和生物仿制药将主要抵消基础压力。瑞士银行的纸币显示，更大的开支节省也将帮助其交易走高。瑞银发起购买保险。特拉维夫上市公","html":"格林尼治时间1015英镑-瑞银(UBS)表示，华尔街高估了Teva的偿债风险，因为其下行模式显示，除了债务需求之外，还有20亿美元的现金。蒂瓦过去的五年受到了糟糕交易和激烈竞争的影响，这使得这家以色列制药公司债台高筑，股价下跌了60%，但瑞银表示，未来前景更加乐观：奥斯特多、阿乔维和生物仿制药将主要抵消基础压力。瑞士银行的纸币显示，更大的开支节省也将帮助其交易走高。瑞银发起购买保险。特拉维夫上市公","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/385718"}
精彩评论